Riskpilot← Back to searchSign inGet full accessClartech AB
ABActiveOrg 5591479935Tagmadsvägen 39Research and experimental development on natural sciences and engineering · NACE 7210Est. 20181-4 employees
Revenue 2024
SEK 425K
-37% vs 2023
EBITDA margin
-13.3%
-179% vs 2023
Equity ratio
25.2%
Financial strength
Net profit 2024
SEK -123K
-490% vs 2023
| Revenue | SEK 425K | -37% |
| EBITDA | SEK -57K | -179% |
| Net profit | SEK -123K | -490% |
| Total assets | SEK 669K | -9% |
| Equity | SEK 168K | -48% |
| Employees | — | — |
Legal name
Clartech AB
Org number
5591479935
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
2 februari 2018
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva läkarverksamhet och konsultverksamhet inom allmänmedicin. Försäljning, forskning och utveckling av proteinbaserade produkter samt konsult- och kursverksamhet i anslutning därtill. Förvaltning och handel med värdepapper. Uppfödning av hästar, bedriva tävlingsverksamhet med hästar samt idka annan därmed förenlig verksamhet.
Address
Tagmadsvägen 39
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 916 | 1 089 | 1 121 | 674 | 425 |
| Staff expenses | — | — | −517 | −245 | −147 |
| EBITDA | −32 | 145 | 199 | 72 | −57 |
| Depreciation & amort. | −40 | −19 | −48 | −19 | −13 |
| EBIT | −72 | 126 | 151 | 53 | −70 |
| Net financials | −4 | −12 | −15 | −12 | −36 |
| Profit before tax | 4 | 84 | 102 | 41 | −123 |
| Tax | −1 | −18 | −21 | −9 | — |
| Net profit | 3 | 66 | 81 | 31 | −123 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 791 | 875 | 777 | 735 | 669 |
| Equity | 233 | 299 | 290 | 322 | 168 |
| Long-term debt | 244 | 178 | 111 | 194 | 230 |
| Short-term debt | 314 | 369 | 313 | 156 | 191 |
| Total debt | 558 | 547 | 424 | 351 | 422 |
EBITDA margin
-13.3%
This company
15.8%
Market median
-184% vs market
20202024
Equity ratio
25.2%
This company
38.2%
Market median
-34% vs market
20202024
Return on equity
-72.8%
This company
18.4%
Market median
-496% vs market
20202024
Net profit margin
-28.8%
This company
8.1%
Market median
-456% vs market
20202024
Asset turnover
0.64×
This company
1.12×
Market median
-43% vs market
20202024
Debt / equity
2.98×
This company
0.62×
Market median
-381% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Clartech AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Elin Matilda Ljunger | Deputy Board Member | 0 companies |
| Mats Peter Clarsund | Chairman | 0 companies |
| Ulla Karin Marianne Clarsund | Board of Directors | 0 companies |